nodes	percent_of_prediction	percent_of_DWPC	metapath
Sodium lauryl sulfate—Myocardial infarction—Mitoxantrone—sarcoma	0.004	0.004	CcSEcCtD
Sodium lauryl sulfate—Abscess—Doxorubicin—sarcoma	0.00397	0.00397	CcSEcCtD
Sodium lauryl sulfate—Extravasation—Epirubicin—sarcoma	0.00389	0.00389	CcSEcCtD
Sodium lauryl sulfate—Dysphagia—Etoposide—sarcoma	0.0038	0.0038	CcSEcCtD
Sodium lauryl sulfate—Arrhythmia—Thiotepa—sarcoma	0.00378	0.00378	CcSEcCtD
Sodium lauryl sulfate—Bronchospasm—Etoposide—sarcoma	0.00374	0.00374	CcSEcCtD
Sodium lauryl sulfate—Hypoaesthesia—Vincristine—sarcoma	0.00374	0.00374	CcSEcCtD
Sodium lauryl sulfate—Cellulitis—Epirubicin—sarcoma	0.00374	0.00374	CcSEcCtD
Sodium lauryl sulfate—Hypocalcaemia—Epirubicin—sarcoma	0.00371	0.00371	CcSEcCtD
Sodium lauryl sulfate—Sweating increased—Etoposide—sarcoma	0.0037	0.0037	CcSEcCtD
Sodium lauryl sulfate—Oliguria—Epirubicin—sarcoma	0.00369	0.00369	CcSEcCtD
Sodium lauryl sulfate—Extravasation—Doxorubicin—sarcoma	0.0036	0.0036	CcSEcCtD
Sodium lauryl sulfate—Ulcer—Epirubicin—sarcoma	0.00359	0.00359	CcSEcCtD
Sodium lauryl sulfate—Creatinine increased—Epirubicin—sarcoma	0.00357	0.00357	CcSEcCtD
Sodium lauryl sulfate—Vision blurred—Thiotepa—sarcoma	0.00348	0.00348	CcSEcCtD
Sodium lauryl sulfate—Cellulitis—Doxorubicin—sarcoma	0.00346	0.00346	CcSEcCtD
Sodium lauryl sulfate—Hypocalcaemia—Doxorubicin—sarcoma	0.00343	0.00343	CcSEcCtD
Sodium lauryl sulfate—Oliguria—Doxorubicin—sarcoma	0.00341	0.00341	CcSEcCtD
Sodium lauryl sulfate—Acute coronary syndrome—Etoposide—sarcoma	0.00334	0.00334	CcSEcCtD
Sodium lauryl sulfate—Renal failure—Etoposide—sarcoma	0.00333	0.00333	CcSEcCtD
Sodium lauryl sulfate—Ulcer—Doxorubicin—sarcoma	0.00332	0.00332	CcSEcCtD
Sodium lauryl sulfate—Myocardial infarction—Etoposide—sarcoma	0.00332	0.00332	CcSEcCtD
Sodium lauryl sulfate—Creatinine increased—Doxorubicin—sarcoma	0.0033	0.0033	CcSEcCtD
Sodium lauryl sulfate—Arrhythmia—Mitoxantrone—sarcoma	0.00327	0.00327	CcSEcCtD
Sodium lauryl sulfate—Fluid retention—Epirubicin—sarcoma	0.00323	0.00323	CcSEcCtD
Sodium lauryl sulfate—Blood urea increased—Epirubicin—sarcoma	0.00321	0.00321	CcSEcCtD
Sodium lauryl sulfate—Convulsion—Thiotepa—sarcoma	0.0032	0.0032	CcSEcCtD
Sodium lauryl sulfate—Anxiety—Thiotepa—sarcoma	0.00313	0.00313	CcSEcCtD
Sodium lauryl sulfate—Dysgeusia—Mitoxantrone—sarcoma	0.00312	0.00312	CcSEcCtD
Sodium lauryl sulfate—Hypoaesthesia—Etoposide—sarcoma	0.00303	0.00303	CcSEcCtD
Sodium lauryl sulfate—Vision blurred—Mitoxantrone—sarcoma	0.003	0.003	CcSEcCtD
Sodium lauryl sulfate—Infection—Thiotepa—sarcoma	0.00299	0.00299	CcSEcCtD
Sodium lauryl sulfate—Oedema—Dactinomycin—sarcoma	0.00299	0.00299	CcSEcCtD
Sodium lauryl sulfate—Fluid retention—Doxorubicin—sarcoma	0.00298	0.00298	CcSEcCtD
Sodium lauryl sulfate—Infection—Dactinomycin—sarcoma	0.00297	0.00297	CcSEcCtD
Sodium lauryl sulfate—Blood urea increased—Doxorubicin—sarcoma	0.00297	0.00297	CcSEcCtD
Sodium lauryl sulfate—Sepsis—Epirubicin—sarcoma	0.00295	0.00295	CcSEcCtD
Sodium lauryl sulfate—Tachycardia—Thiotepa—sarcoma	0.00294	0.00294	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Thiotepa—sarcoma	0.00287	0.00287	CcSEcCtD
Sodium lauryl sulfate—Phlebitis—Epirubicin—sarcoma	0.00286	0.00286	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Dactinomycin—sarcoma	0.00285	0.00285	CcSEcCtD
Sodium lauryl sulfate—Convulsion—Vincristine—sarcoma	0.00283	0.00283	CcSEcCtD
Sodium lauryl sulfate—Convulsion—Mitoxantrone—sarcoma	0.00276	0.00276	CcSEcCtD
Sodium lauryl sulfate—Sepsis—Doxorubicin—sarcoma	0.00273	0.00273	CcSEcCtD
Sodium lauryl sulfate—Cardiac failure congestive—Epirubicin—sarcoma	0.00272	0.00272	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Mitoxantrone—sarcoma	0.00271	0.00271	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Thiotepa—sarcoma	0.0027	0.0027	CcSEcCtD
Sodium lauryl sulfate—Anxiety—Mitoxantrone—sarcoma	0.0027	0.0027	CcSEcCtD
Sodium lauryl sulfate—Renal failure acute—Epirubicin—sarcoma	0.00267	0.00267	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Vincristine—sarcoma	0.00267	0.00267	CcSEcCtD
Sodium lauryl sulfate—Oedema—Vincristine—sarcoma	0.00267	0.00267	CcSEcCtD
Sodium lauryl sulfate—Infection—Vincristine—sarcoma	0.00265	0.00265	CcSEcCtD
Sodium lauryl sulfate—Phlebitis—Doxorubicin—sarcoma	0.00265	0.00265	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Thiotepa—sarcoma	0.00262	0.00262	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Mitoxantrone—sarcoma	0.0026	0.0026	CcSEcCtD
Sodium lauryl sulfate—Oedema—Mitoxantrone—sarcoma	0.0026	0.0026	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Dactinomycin—sarcoma	0.0026	0.0026	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Thiotepa—sarcoma	0.0026	0.0026	CcSEcCtD
Sodium lauryl sulfate—Dysgeusia—Etoposide—sarcoma	0.00259	0.00259	CcSEcCtD
Sodium lauryl sulfate—Renal impairment—Epirubicin—sarcoma	0.00259	0.00259	CcSEcCtD
Sodium lauryl sulfate—Infection—Mitoxantrone—sarcoma	0.00258	0.00258	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Vincristine—sarcoma	0.00258	0.00258	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Dactinomycin—sarcoma	0.00258	0.00258	CcSEcCtD
Sodium lauryl sulfate—Constipation—Thiotepa—sarcoma	0.00257	0.00257	CcSEcCtD
Sodium lauryl sulfate—Shock—Mitoxantrone—sarcoma	0.00256	0.00256	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Vincristine—sarcoma	0.00254	0.00254	CcSEcCtD
Sodium lauryl sulfate—Tachycardia—Mitoxantrone—sarcoma	0.00254	0.00254	CcSEcCtD
Sodium lauryl sulfate—Cerebrovascular accident—Epirubicin—sarcoma	0.00252	0.00252	CcSEcCtD
Sodium lauryl sulfate—Cardiac failure congestive—Doxorubicin—sarcoma	0.00252	0.00252	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Mitoxantrone—sarcoma	0.00251	0.00251	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Vincristine—sarcoma	0.00249	0.00249	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Mitoxantrone—sarcoma	0.00248	0.00248	CcSEcCtD
Sodium lauryl sulfate—Renal failure acute—Doxorubicin—sarcoma	0.00247	0.00247	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Thiotepa—sarcoma	0.00246	0.00246	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Dactinomycin—sarcoma	0.00244	0.00244	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Mitoxantrone—sarcoma	0.00243	0.00243	CcSEcCtD
Sodium lauryl sulfate—Renal impairment—Doxorubicin—sarcoma	0.0024	0.0024	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Vincristine—sarcoma	0.0024	0.0024	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Thiotepa—sarcoma	0.00239	0.00239	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Thiotepa—sarcoma	0.00238	0.00238	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Thiotepa—sarcoma	0.00238	0.00238	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Dactinomycin—sarcoma	0.00236	0.00236	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Dactinomycin—sarcoma	0.00236	0.00236	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Mitoxantrone—sarcoma	0.00233	0.00233	CcSEcCtD
Sodium lauryl sulfate—Loss of consciousness—Etoposide—sarcoma	0.00233	0.00233	CcSEcCtD
Sodium lauryl sulfate—Cerebrovascular accident—Doxorubicin—sarcoma	0.00233	0.00233	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Vincristine—sarcoma	0.00232	0.00232	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Mitoxantrone—sarcoma	0.00232	0.00232	CcSEcCtD
Sodium lauryl sulfate—Blood creatinine increased—Epirubicin—sarcoma	0.00231	0.00231	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Vincristine—sarcoma	0.0023	0.0023	CcSEcCtD
Sodium lauryl sulfate—Convulsion—Etoposide—sarcoma	0.0023	0.0023	CcSEcCtD
Sodium lauryl sulfate—Dehydration—Epirubicin—sarcoma	0.00229	0.00229	CcSEcCtD
Sodium lauryl sulfate—Constipation—Vincristine—sarcoma	0.00228	0.00228	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Mitoxantrone—sarcoma	0.00226	0.00226	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Etoposide—sarcoma	0.00226	0.00226	CcSEcCtD
Sodium lauryl sulfate—Hypokalaemia—Epirubicin—sarcoma	0.00224	0.00224	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Mitoxantrone—sarcoma	0.00224	0.00224	CcSEcCtD
Sodium lauryl sulfate—Constipation—Mitoxantrone—sarcoma	0.00222	0.00222	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Thiotepa—sarcoma	0.00222	0.00222	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Dactinomycin—sarcoma	0.0022	0.0022	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Vincristine—sarcoma	0.00218	0.00218	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Etoposide—sarcoma	0.00216	0.00216	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Thiotepa—sarcoma	0.00216	0.00216	CcSEcCtD
Sodium lauryl sulfate—Infection—Etoposide—sarcoma	0.00215	0.00215	CcSEcCtD
Sodium lauryl sulfate—Abdominal distension—Epirubicin—sarcoma	0.00215	0.00215	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Dactinomycin—sarcoma	0.00214	0.00214	CcSEcCtD
Sodium lauryl sulfate—Blood creatinine increased—Doxorubicin—sarcoma	0.00214	0.00214	CcSEcCtD
Sodium lauryl sulfate—Dysphagia—Epirubicin—sarcoma	0.00213	0.00213	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Thiotepa—sarcoma	0.00213	0.00213	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00213	0.00213	CcSEcCtD
Sodium lauryl sulfate—Dehydration—Doxorubicin—sarcoma	0.00212	0.00212	CcSEcCtD
Sodium lauryl sulfate—Tachycardia—Etoposide—sarcoma	0.00211	0.00211	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Vincristine—sarcoma	0.00211	0.00211	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Vincristine—sarcoma	0.00211	0.00211	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Etoposide—sarcoma	0.00209	0.00209	CcSEcCtD
Sodium lauryl sulfate—Hypokalaemia—Doxorubicin—sarcoma	0.00208	0.00208	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Mitoxantrone—sarcoma	0.00206	0.00206	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Etoposide—sarcoma	0.00206	0.00206	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Thiotepa—sarcoma	0.00206	0.00206	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Mitoxantrone—sarcoma	0.00205	0.00205	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Mitoxantrone—sarcoma	0.00205	0.00205	CcSEcCtD
Sodium lauryl sulfate—Bronchitis—Epirubicin—sarcoma	0.00205	0.00205	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Dactinomycin—sarcoma	0.00204	0.00204	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Etoposide—sarcoma	0.00202	0.00202	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Thiotepa—sarcoma	0.00199	0.00199	CcSEcCtD
Sodium lauryl sulfate—Abdominal distension—Doxorubicin—sarcoma	0.00199	0.00199	CcSEcCtD
Sodium lauryl sulfate—Dysphagia—Doxorubicin—sarcoma	0.00197	0.00197	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Vincristine—sarcoma	0.00197	0.00197	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Etoposide—sarcoma	0.00194	0.00194	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Etoposide—sarcoma	0.00193	0.00193	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Mitoxantrone—sarcoma	0.00192	0.00192	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Vincristine—sarcoma	0.00192	0.00192	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Thiotepa—sarcoma	0.00191	0.00191	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Dactinomycin—sarcoma	0.0019	0.0019	CcSEcCtD
Sodium lauryl sulfate—Rash—Thiotepa—sarcoma	0.0019	0.0019	CcSEcCtD
Sodium lauryl sulfate—Bronchitis—Doxorubicin—sarcoma	0.0019	0.0019	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Thiotepa—sarcoma	0.0019	0.0019	CcSEcCtD
Sodium lauryl sulfate—Headache—Thiotepa—sarcoma	0.00189	0.00189	CcSEcCtD
Sodium lauryl sulfate—Rash—Dactinomycin—sarcoma	0.00188	0.00188	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Etoposide—sarcoma	0.00188	0.00188	CcSEcCtD
Sodium lauryl sulfate—Renal failure—Epirubicin—sarcoma	0.00187	0.00187	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Mitoxantrone—sarcoma	0.00186	0.00186	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Etoposide—sarcoma	0.00186	0.00186	CcSEcCtD
Sodium lauryl sulfate—Constipation—Etoposide—sarcoma	0.00185	0.00185	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Vincristine—sarcoma	0.00183	0.00183	CcSEcCtD
Sodium lauryl sulfate—Nausea—Thiotepa—sarcoma	0.00179	0.00179	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Mitoxantrone—sarcoma	0.00178	0.00178	CcSEcCtD
Sodium lauryl sulfate—Nausea—Dactinomycin—sarcoma	0.00177	0.00177	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Etoposide—sarcoma	0.00177	0.00177	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Vincristine—sarcoma	0.00177	0.00177	CcSEcCtD
Sodium lauryl sulfate—Renal failure—Doxorubicin—sarcoma	0.00173	0.00173	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Etoposide—sarcoma	0.00172	0.00172	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Etoposide—sarcoma	0.00171	0.00171	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Etoposide—sarcoma	0.00171	0.00171	CcSEcCtD
Sodium lauryl sulfate—Hypoaesthesia—Epirubicin—sarcoma	0.0017	0.0017	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Vincristine—sarcoma	0.0017	0.0017	CcSEcCtD
Sodium lauryl sulfate—Rash—Vincristine—sarcoma	0.00168	0.00168	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Vincristine—sarcoma	0.00168	0.00168	CcSEcCtD
Sodium lauryl sulfate—Headache—Vincristine—sarcoma	0.00167	0.00167	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Mitoxantrone—sarcoma	0.00165	0.00165	CcSEcCtD
Sodium lauryl sulfate—Rash—Mitoxantrone—sarcoma	0.00164	0.00164	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Mitoxantrone—sarcoma	0.00164	0.00164	CcSEcCtD
Sodium lauryl sulfate—Headache—Mitoxantrone—sarcoma	0.00163	0.00163	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Etoposide—sarcoma	0.00159	0.00159	CcSEcCtD
Sodium lauryl sulfate—Nausea—Vincristine—sarcoma	0.00159	0.00159	CcSEcCtD
Sodium lauryl sulfate—Hypoaesthesia—Doxorubicin—sarcoma	0.00157	0.00157	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Etoposide—sarcoma	0.00155	0.00155	CcSEcCtD
Sodium lauryl sulfate—Nausea—Mitoxantrone—sarcoma	0.00154	0.00154	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Etoposide—sarcoma	0.00153	0.00153	CcSEcCtD
Sodium lauryl sulfate—Arrhythmia—Epirubicin—sarcoma	0.00152	0.00152	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Etoposide—sarcoma	0.00148	0.00148	CcSEcCtD
Sodium lauryl sulfate—Flatulence—Epirubicin—sarcoma	0.00146	0.00146	CcSEcCtD
Sodium lauryl sulfate—Dysgeusia—Epirubicin—sarcoma	0.00145	0.00145	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Etoposide—sarcoma	0.00143	0.00143	CcSEcCtD
Sodium lauryl sulfate—Arrhythmia—Doxorubicin—sarcoma	0.00141	0.00141	CcSEcCtD
Sodium lauryl sulfate—Vision blurred—Epirubicin—sarcoma	0.0014	0.0014	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Etoposide—sarcoma	0.00137	0.00137	CcSEcCtD
Sodium lauryl sulfate—Rash—Etoposide—sarcoma	0.00136	0.00136	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Etoposide—sarcoma	0.00136	0.00136	CcSEcCtD
Sodium lauryl sulfate—Headache—Etoposide—sarcoma	0.00135	0.00135	CcSEcCtD
Sodium lauryl sulfate—Flatulence—Doxorubicin—sarcoma	0.00135	0.00135	CcSEcCtD
Sodium lauryl sulfate—Dysgeusia—Doxorubicin—sarcoma	0.00135	0.00135	CcSEcCtD
Sodium lauryl sulfate—Syncope—Epirubicin—sarcoma	0.00133	0.00133	CcSEcCtD
Sodium lauryl sulfate—Palpitations—Epirubicin—sarcoma	0.00131	0.00131	CcSEcCtD
Sodium lauryl sulfate—Loss of consciousness—Epirubicin—sarcoma	0.00131	0.00131	CcSEcCtD
Sodium lauryl sulfate—Vision blurred—Doxorubicin—sarcoma	0.00129	0.00129	CcSEcCtD
Sodium lauryl sulfate—Convulsion—Epirubicin—sarcoma	0.00129	0.00129	CcSEcCtD
Sodium lauryl sulfate—Nausea—Etoposide—sarcoma	0.00128	0.00128	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Epirubicin—sarcoma	0.00126	0.00126	CcSEcCtD
Sodium lauryl sulfate—Anxiety—Epirubicin—sarcoma	0.00126	0.00126	CcSEcCtD
Sodium lauryl sulfate—Syncope—Doxorubicin—sarcoma	0.00123	0.00123	CcSEcCtD
Sodium lauryl sulfate—Palpitations—Doxorubicin—sarcoma	0.00121	0.00121	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Epirubicin—sarcoma	0.00121	0.00121	CcSEcCtD
Sodium lauryl sulfate—Oedema—Epirubicin—sarcoma	0.00121	0.00121	CcSEcCtD
Sodium lauryl sulfate—Loss of consciousness—Doxorubicin—sarcoma	0.00121	0.00121	CcSEcCtD
Sodium lauryl sulfate—Infection—Epirubicin—sarcoma	0.0012	0.0012	CcSEcCtD
Sodium lauryl sulfate—Shock—Epirubicin—sarcoma	0.00119	0.00119	CcSEcCtD
Sodium lauryl sulfate—Convulsion—Doxorubicin—sarcoma	0.00119	0.00119	CcSEcCtD
Sodium lauryl sulfate—Tachycardia—Epirubicin—sarcoma	0.00118	0.00118	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Epirubicin—sarcoma	0.00117	0.00117	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Doxorubicin—sarcoma	0.00117	0.00117	CcSEcCtD
Sodium lauryl sulfate—Anxiety—Doxorubicin—sarcoma	0.00117	0.00117	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Epirubicin—sarcoma	0.00116	0.00116	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Epirubicin—sarcoma	0.00113	0.00113	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Doxorubicin—sarcoma	0.00112	0.00112	CcSEcCtD
Sodium lauryl sulfate—Oedema—Doxorubicin—sarcoma	0.00112	0.00112	CcSEcCtD
Sodium lauryl sulfate—Infection—Doxorubicin—sarcoma	0.00111	0.00111	CcSEcCtD
Sodium lauryl sulfate—Shock—Doxorubicin—sarcoma	0.0011	0.0011	CcSEcCtD
Sodium lauryl sulfate—Tachycardia—Doxorubicin—sarcoma	0.00109	0.00109	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Epirubicin—sarcoma	0.00109	0.00109	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Doxorubicin—sarcoma	0.00108	0.00108	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Epirubicin—sarcoma	0.00108	0.00108	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Doxorubicin—sarcoma	0.00107	0.00107	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Epirubicin—sarcoma	0.00105	0.00105	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Doxorubicin—sarcoma	0.00105	0.00105	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Epirubicin—sarcoma	0.00104	0.00104	CcSEcCtD
Sodium lauryl sulfate—Constipation—Epirubicin—sarcoma	0.00104	0.00104	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Doxorubicin—sarcoma	0.00101	0.00101	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Doxorubicin—sarcoma	0.001	0.001	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Epirubicin—sarcoma	0.000991	0.000991	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Doxorubicin—sarcoma	0.000975	0.000975	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Doxorubicin—sarcoma	0.000967	0.000967	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Epirubicin—sarcoma	0.000963	0.000963	CcSEcCtD
Sodium lauryl sulfate—Constipation—Doxorubicin—sarcoma	0.000959	0.000959	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Epirubicin—sarcoma	0.000958	0.000958	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Epirubicin—sarcoma	0.000958	0.000958	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Doxorubicin—sarcoma	0.000917	0.000917	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Epirubicin—sarcoma	0.000893	0.000893	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Doxorubicin—sarcoma	0.000891	0.000891	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Doxorubicin—sarcoma	0.000887	0.000887	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Doxorubicin—sarcoma	0.000887	0.000887	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Epirubicin—sarcoma	0.00087	0.00087	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Epirubicin—sarcoma	0.000857	0.000857	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Epirubicin—sarcoma	0.000829	0.000829	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Doxorubicin—sarcoma	0.000826	0.000826	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Doxorubicin—sarcoma	0.000805	0.000805	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Epirubicin—sarcoma	0.000801	0.000801	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Doxorubicin—sarcoma	0.000793	0.000793	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Epirubicin—sarcoma	0.000771	0.000771	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Doxorubicin—sarcoma	0.000767	0.000767	CcSEcCtD
Sodium lauryl sulfate—Rash—Epirubicin—sarcoma	0.000764	0.000764	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Epirubicin—sarcoma	0.000763	0.000763	CcSEcCtD
Sodium lauryl sulfate—Headache—Epirubicin—sarcoma	0.000759	0.000759	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Doxorubicin—sarcoma	0.000742	0.000742	CcSEcCtD
Sodium lauryl sulfate—Nausea—Epirubicin—sarcoma	0.00072	0.00072	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Doxorubicin—sarcoma	0.000713	0.000713	CcSEcCtD
Sodium lauryl sulfate—Rash—Doxorubicin—sarcoma	0.000707	0.000707	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Doxorubicin—sarcoma	0.000706	0.000706	CcSEcCtD
Sodium lauryl sulfate—Headache—Doxorubicin—sarcoma	0.000703	0.000703	CcSEcCtD
Sodium lauryl sulfate—Nausea—Doxorubicin—sarcoma	0.000666	0.000666	CcSEcCtD
